PF 1715 is a by-product from the R&D synthesis towards Bumetanide Lactose Adduct Impurity (B810335), the lactose adduct impurity of Bumetanide (B689550), a diuretic.
Ward, A., et al.: Drugs, 28, 426 (1984); Gradeen, C.Y, et al.: J. Anal. Toxicol., 14, 123 (1990); Tata, P.N.V., et al.: Anal. Profiles Drug Subs. Excip., 22, 107 (1993);